Total Funding
21
56
Total FundingSeries A raised
Growth Score
-4 pts
Heat Score
-8 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience
32462
ReLive is spearheading regenerative cell therapies to address unmet needs in the areas of orthopedic sports medicine and plastic surgery.
- Xing Zhao: Founder, Chairman, and Global CEOPast Role: SQZ Biotech, Co-Founder and Board Member
- Ying Zhou: Co-Founder, President, and Global CTO
About the Company
ReLive is a biotechnology company that develops orthopedic sports medicine and plastic and reconstructive surgery projects based on regenerative medicine and cell therapy science.
Women Founded
